PTC Therapeutics: A Steady Performer Trading Around Fair Value [Seeking Alpha]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Seeking Alpha
PTC Therapeutics (PTCTvariety of technologiesPTC Looks to Continue its Steady Growth TrajectoryI really like to see companies with a clear vision and consistent execution of that vision. PTC easily checks both of those boxes. It has several marketed products that are still growing in sales, but they also could have substantial upside over the next few years based on growth and approved products and further pipeline development.Figure 1:(Source:Company corporate presentation)As you can see from Figure 1, PTC’s revenue this year will likely be around 10x what it was as recently as 2015, and management is projecting over an additional 4x growth in revenue just through 2023. It’s also worth noting that there’s a growing margin of safety if management’s estimates can be trusted, because they project the company should hit its revenue targets in the coming years even if you ignore the majority of its pipeline.Figure 2:(Source: Company corporate presentation)While I’m personally a little ske
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts [Seeking Alpha]Seeking Alpha
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™PR Newswire
- PTC Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $30.00 price target on the stock, up previously from $28.00.MarketBeat
PTCT
Earnings
- 4/25/24 - Beat
PTCT
Sec Filings
- 5/10/24 - Form 4
- 5/8/24 - Form 4
- 5/7/24 - Form 144
- PTCT's page on the SEC website